MNPR

MONOPAR THERAPEUTICS INC

MNPR·61023L207·US·Common Stock·Healthcare - Biotechnology-Activist

MNPR (MONOPAR THERAPEUTICS INC) is held by 57 institutional investors as of Q1 2026. Largest holders: Janus Henderson Group Ltd. ($72.1M), RA CAPITAL MANAGEMENT, L.P. ($36.6M), BlackRock, Inc. ($17.3M). Net institutional sentiment: Mixed.

57
Holders
Avg rating(11 Elite)
$245M
Total Value
64% (63)
Fund Consensus
36 buying - 20 selling
MNPRSmart Money Verdict
View all
Held by 57 funds
11 elite
Who's Trading
ActivistSVSaturn V Capital Management LP5.2%May 15, 2026
ActivistADAdage Capital Management, L.P.6.2%May 13, 2026
ActivistRA Capital Management, L.P.RA Capital Management, L.P.9.9%Feb 17, 2026
ActivistAPAstraZeneca PLC7.8%Feb 6, 2026
ActivistTPTactic Pharma LLC0.0%Jan 30, 2026
InsiderVAVu Quan AnhBuy $105KDec 26, 2025
InsiderKJKLAUSNER ARTHUR JSell $312KDec 18, 2025
InsiderKJKLAUSNER ARTHUR JSell $31KDec 18, 2025
ActivistJANUS HENDERSON GROUP PLCJANUS HENDERSON GROUP PLC19.5%Nov 14, 2025
InsiderTLTactic Pharma LLCSell $35.0MSep 24, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
1.3M$72.1M0.0%+247.13%
0
Unchanged
667,207$36.6M0.4%+218.33%
0
Increased
316,567(+24.2%)$17.3M0.0%+153.02%
34
Decreased
309,195(-51.6%)$16.9M0.0%+272.89%
0
Increased
226,526(+114.2%)$12.4M0.0%+83.67%
45
New
218,463$12M0.0%+105.47%
39
Decreased
174,342(-22.9%)$9.6M0.0%+40.45%
0
Increased
136,443(+327.6%)$7.5M0.0%+93.94%
44
Increased
100,000(+150.0%)$5.5M0.0%+82.29%
44
Increased
99,918(+0.9%)$5.5M0.0%+203.00%
27
Increased
88,355(+5.2%)$4.8M0.0%+95.77%
28
Increased
78,618(+21.2%)$4.3M0.0%+76.75%
32
New
63,119$3.5M0.0%+105.47%
37
Increased
59,699(+838.2%)$3.3M0.0%+103.40%
43
Increased
58,436(+1051.9%)$3.2M0.0%+101.04%
43
Decreased
52,951(-30.9%)$2.9M0.0%+70.01%
0
Increased
47,702(+109.9%)$2.6M0.0%+83.27%
42
New
45,987$2.5M0.0%+105.47%
36
Increased
42,434(+30.4%)$2.3M0.0%+71.94%
33
Increased
39,436(+827.9%)$2.2M0.0%+114.86%
42

Showing 1-20 of 63

1 / 4

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used